RAVAROTTO, VERDIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.155
EU - Europa 240
AS - Asia 181
AF - Africa 2
OC - Oceania 1
Totale 2.579
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.154
CN - Cina 153
IT - Italia 83
SE - Svezia 42
FI - Finlandia 28
DE - Germania 25
SI - Slovenia 14
VN - Vietnam 14
GB - Regno Unito 13
IN - India 11
NL - Olanda 7
UA - Ucraina 7
CH - Svizzera 5
MK - Macedonia 4
FR - Francia 3
IE - Irlanda 3
AT - Austria 2
BG - Bulgaria 2
PH - Filippine 2
UG - Uganda 2
BE - Belgio 1
CA - Canada 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 2.579
Salva come PNG Salva come JPEG
Città #
Fairfield 433
Chandler 316
Ashburn 195
Woodbridge 186
Cambridge 145
Seattle 135
Wilmington 116
Houston 115
Ann Arbor 92
Beijing 45
Padova 39
San Diego 37
Medford 34
Princeton 34
Des Moines 31
Helsinki 24
Boardman 22
Nanjing 19
New York 19
Dong Ket 14
Roxbury 14
Jinan 10
Nanchang 8
Hefei 7
Shanghai 7
Cagliari 6
Falls Church 6
Guangzhou 5
Kunming 5
Hebei 4
Kilburn 4
Redwood City 4
Amsterdam 3
Changsha 3
Dublin 3
Fuzhou 3
Hangzhou 3
Lanzhou 3
Las Vegas 3
Lausanne 3
Los Angeles 3
Norwalk 3
Washington 3
Bitola 2
Chongqing 2
Edinburgh 2
Esslingen am Neckar 2
Jiaxing 2
Kampala 2
Kharkiv 2
Lappeenranta 2
Ningbo 2
Ogden 2
Palo Alto 2
Phoenix 2
Prilep 2
Pune 2
Rome 2
San Jose 2
Selvazzano Dentro 2
Sofia 2
Taizhou 2
Vienna 2
Voghera 2
Zhengzhou 2
Zurich 2
Atlanta 1
Avellino 1
Baotou 1
Borås 1
Brussels 1
Carmichael 1
Carol Stream 1
Chengdu 1
Chiswick 1
Christchurch 1
Dearborn 1
Fabriano 1
Frankfurt am Main 1
Gunzenhausen 1
Islington 1
London 1
Lucca 1
Miami 1
Milan 1
Mission 1
Munich 1
Naples 1
Ottawa 1
Paris 1
Prescot 1
Rockville 1
Shenyang 1
Southwark 1
Stockholm 1
Tianjin 1
Volpago del Montello 1
Wuhan 1
Xian 1
Totale 2.243
Salva come PNG Salva come JPEG
Nome #
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 150
Searching for an additional treatment to slowing the progression of Fabry disease 135
Oxidative stress - chronic kidney disease - cardiovascular disease: A vicious circle 129
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 120
Is heme oxygenase-1 turning out to be a key positive regulator for oxidative stress? 108
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement? 107
Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications. 99
Comment on “Vitamin E supplementation improves high-density lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis” by Mune et al. Clinical Nephrology DOI 10.5414/CN109197 e-pub: April 9, 2018 97
Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients. 96
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 95
Bartter's and Gitelman's syndromes 94
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 92
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 86
SP021CARDIOVASCULAR-RENAL REMODELING IN FABRY DISEASE: POSSIBLE INVOLVEMENT OF OXIDATIVE STRESS. A MOLECULAR BIOLOGY APPROACH 85
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 84
Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism. 76
Gitelman's Syndrome: characterization of a novel c.1181G>A point mutation and functional classification of the known mutations. 75
Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension. 67
The importance of chronic magnesium deficiency in human disease and the Gitelman’s syndrome paradox 67
ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman’s and Bartter’s Syndromes. 65
Oxidative stress in hypertension and cardiovascular-renal remodeling:focus on the renin-angiotensin-aldosterone system 64
Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients 62
Molecular Characterization of A Novel Mutation In The Renal NaCl Cotransporter Causing Gitelman'€™s Syndrome By Impairing Transporter Trafficking 60
Could nutritional therapy take us further in our approaches to Fabry disease? 58
ROCK (RhoA/Rho Kinase) in Cardiovascular–Renal Pathophysiology: A Review of New Advancements 55
The counter-regulatory arm of the renin-angiotensin system and COVID-19: insights from Gitelman's and Bartter's syndromes. 45
Tracing Angiotensin II's Yin -Yang effects on cardiovascular-renal pathophysiology. Yin and yang systems of Ang II. 44
The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease 40
Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach 38
The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman’s and Bartter’s Syndromes 35
Rho kinase activity and atrial fibrillation: insights fromchronic kidney disease and dialysis patients. 34
Reduced oxidative stress in ADPKD patients treated with tolvaptan. 29
Relationship between NOX4 level and angiotensin II signaling in Gitelman's syndrome. Implications with hypertension. 28
Rho kinase inhibition: from hypertension to cardiovascular-renal remodeling and more. 26
The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study 24
Molecular aspects of the altered Angiotensin II signaling in Gitelman’s syndrome 19
Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies. 18
Gitelman’s and Bartter’s syndromes: from genetics to the molecular basis of hypertension and more. 14
Totale 2.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.973
article - articoli 8.897
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 496
Totale 19.366
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019160 0 0 0 0 0 0 0 0 0 0 88 72
2019/2020713 54 33 22 138 63 36 93 73 88 43 55 15
2020/2021358 24 20 22 20 10 13 31 30 48 42 30 68
2021/2022480 22 44 34 32 24 52 30 38 30 20 34 120
2022/2023537 87 68 40 78 79 62 2 35 55 0 26 5
2023/2024240 12 25 23 22 26 54 37 15 14 11 1 0
Totale 2.620